EVOQ Therapeutics
San Diego, United States· Est. 2016
EVOQ Therapeutics develops groundbreaking NanoDisc technology to restore immune tolerance and treat autoimmune diseases like Type 1 Diabetes, Celiac Disease, and Lupus. Learn more about our approach.
Private Company
Total funding raised: $22M
About
EVOQ Therapeutics develops groundbreaking NanoDisc technology to restore immune tolerance and treat autoimmune diseases like Type 1 Diabetes, Celiac Disease, and Lupus. Learn more about our approach.
Vaccines
Funding History
2Total raised:$22M
Series A$20MJun 15, 2021
Grant$2MMar 15, 2020